The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Emerging role of advanced glycation-end products (AGEs) in the pathobiology of eye diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591 · cited 21×
“Scientific evidence indicates that advanced glycation takes place in many cells and tissues that compose the visual system; this presents a common pathogenic factor in many disorders of the eye such as age-related macular degeneration (AMD), cataract and diabetic retinopathy (DR) (Stitt, 2005).”
BackgroundInfluentialAdvanced glycation end-products: A review
Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597 · cited 2×
“Intraocular VEGF levels are increased in diabetic patients where there is a significant correlation between AGEs and the development of diabetic vasculopathy (Aiello et al., 1994; Fonseca et al., 1996; Singh et al., 2001a, 2001b).”
BackgroundAdvanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261
Understanding RAGE, the receptor for advanced glycation end products
Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297 · cited 3×
“RAGE acts as a multiligand binder for several molecules including amyloid-b peptides, amyloid A, S100/calgranulins, amphoterin, high-mobility group box-1 (HMGB1) and AGEs (Bierhaus et al., 2005) (Fig.”
BackgroundInfluentialHypoxia-inducible factor 1: master regulator of O2 homeostasis
Semenza, G. L. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80016-6 · Cited by 1,092
Ramasamy, R., Vannucci, S. J., Yan, S. S. D., Herold, K., Yan, S. F., & Schmidt, A. M. (2005) · Glycobiology · doi:10.1093/glycob/cwi053 · Cited by 834
Advanced glycoxidation end products in commonly consumed foods
Goldberg, T., Cai, W., Peppa, M., Dardaine, V., Baliga, B. S., Uribarri, J., & Vlassara, H. (2004) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2004.05.214 · Cited by 744 · cited 2×
“…and Eye Research (2014), http://dx.doi.org/1 directly correlate with the content of other lipid or protein AGEs (such as MG or malonyl-dialdehyde) in food, suggesting the estimation of CML as a surrogate marker in foods, other human fluids and tissues (Goldberg et al., 2004; Vlassara et al., 2002).”
BackgroundVlassara, H., Cai, W., Crandall, J., Goldberg, T., Oberstein, R., Dardaine, V., Peppa, M., & Rayfield, E. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242407999 · Cited by 668 · cited 3×
“…and Eye Research (2014), http://dx.doi.org/1 directly correlate with the content of other lipid or protein AGEs (such as MG or malonyl-dialdehyde) in food, suggesting the estimation of CML as a surrogate marker in foods, other human fluids and tissues (Goldberg et al., 2004; Vlassara et al., 2002).”
The dynamic nature of Bruch's membrane
Booij, J. C., Baas, D. C., Beisekeeva, J., Gorgels, T. G. M. F., & Bergen, A. A. B. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.08.003 · Cited by 581
The RAGE axis: A fundamental mechanism signaling danger to the vulnerable vasculature
Yan, S. F., Ramasamy, R., & Schmidt, A. M. (2010) · Circulation Research · doi:10.1161/circresaha.109.212217 · Cited by 381
Rosca, M. G., Mustata, T. G., Kinter, M. T., Ozdemir, A. M., Kern, T. S., Szweda, L. I., Brownlee, M., Monnier, V. M., & Weiss, M. F. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00415.2004 · Cited by 354 · cited 1×
“Intracellular AGEs directly bind and alter the structure and function of electron transport chain mitochondrial proteins thus inhibiting oxidative ATP synthesis and use (Rosca et al., 2005).”
BackgroundBucciarelli, L. G., Wendt, T., Rong, L., Lalla, E., Hofmann, M. A., Goova, M. T., Taguchi, A., Yan, S. F., Yan, S. D., Stern, D. M., et al. (2002) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-002-8491-x · Cited by 304
Structural Basis for Pattern Recognition by the Receptor for Advanced Glycation End Products (RAGE)
Xie, J., Reverdatto, S., Frolov, A., Hoffmann, R., Burz, D. S., & Shekhtman, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801622200 · Cited by 252 · cited 2×
“Also there is strong evidence that RAGE interacts with the negatively charged patches of the AGE-modified proteins (Xie et al., 2008; Park et al., 2010; Xue et al., 2011).”
BackgroundMeat consumption, diabetes, and its complications
Feskens, E. J. M., Sluik, D., & van Woudenbergh, G. J. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0365-0 · Cited by 248 · cited 1×
“Thus, there is a necessity of changing everyday dietary habits towards diets low in red meat and processed under moderate temperatures, in order to reduce exogenous AGEs intake and potentially prevent diabetic complications (Feskens et al., 2013; Stitt, 2001; Xu et al., 2003).”
BackgroundRegulation of Vascular Endothelial Growth Factor Expression by Advanced Glycation End Products
Treins, C., Giorgetti-Peraldi, S., Murdaca, J., & Van Obberghen, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106534200 · Cited by 191
Yoshida, N., Okumura, K.-I., & Aso, Y. (2005) · Metabolism · doi:10.1016/j.metabol.2004.09.014 · Cited by 138 · cited 1×
“Furthermore, pentosidine levels have been associated with arterial thickness and stiffness (Yoshida et al., 2005).”
BackgroundReceptor for advanced glycation end products and age-related macular degeneration
Howes, K. A., Liu, Y., Dunaief, J. L., Milam, A., Frederick, J. M., Marks, A., & Baehr, W. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0404 · Cited by 131
Wang, M. Y., Ross-Cisneros, F. N., Aggarwal, D., Liang, C.-Y., & Sadun, A. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0513-4 · Cited by 38
Cited by
The progress in understanding and treatment of diabetic retinopathy
Stitt, A. W., Curtis, T. M., Chen, M., Medina, R. J., McKay, G. J., Jenkins, A., Gardiner, T. A., Lyons, T. J., Hammes, H.-P., Simó, R., et al. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.08.001 · Cited by 1,164
Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy
Xu, J., Chen, L.-J., Yu, J., Wang, H.-J., Zhang, F., Liu, Q., & Wu, J. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000491897 · Cited by 204
Rudraraju, M., Narayanan, S. P., & Somanath, P. R. (2021) · Life · doi:10.3390/life12010033 · Cited by 15
“Deposition of AGE adducts in mice induced REC-barrier disruption and retinal capillary hyperpermeability [31,62] through VEGF production [63], suggesting AGE might be a better candidate to mimic DR effects in ECs in culture.”
Background
Metadata
- Authors
- Kandarakis, S. A., Piperi, C., Topouzis, F., & Papavassiliou, A. G.
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 42
- Pages
- 85-102
- ISSN
- 1350-9462 (ISSN-L)
- OpenAlex
- W2009407060
- Cited by
- 158
- References
- 18
- FWCI
- 7.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.